Tracy L Fink

US Patent:

8246986, Aug 21, 2012

Filed:

Sep 23, 2004

Appl. No.:

10/950003

Inventors:

Evangeline Cruz - Hayward CA, US
Gregory Ruhlmann - Cupertino CA, US
Brenda Pollock - Cupertino CA, US
Sherry Li - Cupertino CA, US
Carmelita Garcia - Newark CA, US
Alfredo M. Wong - Sunnyvale CA, US
Ryan Bronz - Cupertino CA, US
Tracy Fink - Campbell CA, US
David Edgren - Los Altos CA, US

Assignee:

Alza Corporation - Vacaville CA

International Classification:

A61K 9/24
A61K 9/22
A61K 9/54

US Classification:

424464, 424458, 424468, 424472

Abstract:

Aqueous drug coatings including at least one insoluble drug, wherein the insoluble drug accounts for about 85 wt % to about 97 wt % of the drug coatings are described. Such drug coatings may include only one insoluble drug, two or more insoluble drugs, or one or more insoluble drugs in combination with one or more soluble drugs.

US Patent:

20040010000, Jan 15, 2004

Filed:

Apr 25, 2003

Appl. No.:

10/423454

Inventors:

Atul Ayer - Palo Alto CA, US
Padmaja Shivanand - Los Altos CA, US
Nishit Modi - Sunnyvale CA, US
Sonya Seroff - San Jose CA, US
Michael DesJardin - Sunnyvale CA, US
Tracy Fink - Campbell CA, US
Linda Hearney - Saratoga CA, US
Deborah Johnson - Palo Alto CA, US
Clark Allphin - Mountain View CA, US

International Classification:

A61K031/485
A61K009/24

US Classification:

514/282000, 424/473000

Abstract:

Dosage forms and methods for the controlled release of oxycodone over a prolonged period of time are described. The sustained release dosage forms provide therapeutically effective average steady-state plasma oxycodone concentrations when administered once per day. This once-a-day dosing regimen results in only one peak plasma oxycodone concentration occurrence in each 24 hour period that occurs at a later time after administration and exhibits a lesser magnitude than the peak plasma oxycodone concentration that occurs following administration of oxycodone in an immediate-release dosage form and other prior art extended release dosage forms.

US Patent:

20110318392, Dec 29, 2011

Filed:

Apr 11, 2011

Appl. No.:

13/084462

Inventors:

Evangeline Cruz - Hayward CA, US
Gregory Ruhlmann - Cupertino CA, US
Brenda Pollock - Cupertino CA, US
Sherry Li - Cupertino CA, US
Carmelita Garcia - Newark CA, US
Alfredo M. Wong - Sunnyvale CA, US
Ryan Bronz - Cupertino CA, US
Tracy Fink - Campbell CA, US
David Edgren - Los Altos CA, US

International Classification:

A61K 9/00
A61P 25/04
A61P 29/00
A61K 31/167
A61K 31/485

US Classification:

424400, 514629, 514282

Abstract:

The present invention is directed to aqueous drug coatings that include at least one insoluble drug, wherein the drug accounts for about 85 wt % to about 97 wt % of the drug coatings. A drug coating according to the present invention may include only one insoluble drug, two or more insoluble drugs, or one or more insoluble drugs in combination with one or more soluble drugs. The present invention also includes drug coating formulations suitable for providing drug coatings according to the present invention and dosage forms that include a drug coating according to the present invention.

US Patent:

20120165361, Jun 28, 2012

Filed:

Mar 6, 2012

Appl. No.:

13/412840

Inventors:

Evangeline Cruz - Hayward CA, US
Gregory Ruhlmann - Cupertino CA, US
Brenda Pollock - Cupertino CA, US
Sherry Li - Cupertino CA, US
Carmelita Garcia - Newark CA, US
Alfredo M. Wong - Sunnyvale CA, US
Ryan Bronz - Cupertino CA, US
Tracy Fink - Campbell CA, US
David Edgren - Los Altos CA, US

International Classification:

A61K 31/485
A61P 25/04
A61P 29/00
A61K 31/167
A61K 47/38

US Classification:

514282, 514629, 5147725, 514781

Abstract:

The present invention is directed to aqueous drug coatings that include at least one insoluble drug, wherein the drug accounts for about 85 wt % to about 97 wt % of the drug coatings. A drug coating according to the present invention may include only one insoluble drug, two or more insoluble drugs, or one or more insoluble drugs in combination with one or more soluble drugs. The present invention also includes drug coating formulations suitable for providing drug coatings according to the present invention and dosage forms that include a drug coating according to the present invention.